Results 11 to 20 of about 37,917 (298)
DURATION OF DUAL ANTIPLATELET THERAPY
Атеротромбоз, 2016 The review article updates on the key challenge in the present-day cardiology duration of dual antiplatelet therapy (DAPT) in patients with a history of acute coronary syndrome.
O. L. Barbarash
doaj +4 more sources
Type and Duration of Dual Antiplatelet Therapy in Complex Percutaneous Coronary Intervention [PDF]
US Cardiology Review, 2020 Complex percutaneous coronary intervention (PCI) patients are a high-risk population for ischemic complications. Antiplatelet therapy in such patients remains controversial, as the beneficial effects of more potent agents use or prolonged dual ...
Dimitrios Alexopoulos +2 more
doaj +2 more sources
Surgical tracheotomy performed with and without dual antiplatelet therapy
Open Medicine, 2014 Some patients who need dual antiplatelet therapy sometimes require tracheotomy. Aim of this study was to compare the rate of complications during and after surgical tracheotomy between patients requiring dual antiplatelet therapy and those without dual ...
Markota Andrej +2 more
doaj +2 more sources
Dual Antiplatelet Therapy (DAPT) versus No Antiplatelet Therapy and Incidence of Major Bleeding in Patients on Venoarterial Extracorporeal Membrane Oxygenation. [PDF]
PLoS ONE, 2016 Bleeding is a frequent complication in patients on venoarterial extracorporeal membrane oxygenation (VA-ECMO). An indication for dual antiplatelet therapy due to coronary stent implantation is present in a considerable number of these patients.
Dawid L Staudacher +5 more
doaj +2 more sources
Dual Antiplatelet Therapy: A Concise Review for Clinicians
Life, 2023 Dual antiplatelet therapy (DAPT) combines two antiplatelet agents to decrease the risk of thrombotic complications associated with atherosclerotic cardiovascular diseases. Emerging data about the duration of DAPT is being published continuously. New approaches are trying to balance the time, benefits, and risks for patients taking DAPT for established ...
Hafeez Ul Hassan Virk +9 more
core +8 more sources
Shortened Duration of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Contemporary Clinical Review [PDF]
Interventional Cardiology: Reviews, Research, Resources, 2023 Percutaneous coronary intervention with stent implantation is an integral aspect of minimally interventional cardiac procedures. The technology and techniques behind stent design and implantation have evolved rapidly over several decades.
Kevin S Tang +4 more
doaj +2 more sources
Dual Antiplatelet Therapy in Coronary Artery Disease [PDF]
Cardiology and Therapy, 2020 Acute coronary syndrome (ACS) is principally driven by platelet aggregation. Dual antiplatelet therapy (DAPT) has demonstrated a reduction in recurrent ischemic events.
Raghav Sharma +3 more
doaj +3 more sources
Radiology Case ReportsDual antiplatelet therapy is commonly used to treat or prevent thromboembolic events in patients with deep vein thrombosis, pulmonary embolism, atrial fibrillation, in patients after coronary artery stenting, cerebral artery stenting or artificial heart ...
Nguyen The Anh +6 more
doaj +2 more sources
Validation of the Asian-Dual Antiplatelet Therapy Score. [PDF]
Korean Circ JAn individualized approach is recommended for prescribing dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI). Asian-DAPT (ADAPT) scores were developed to assess both ischemic and bleeding risks in Asian populations. This study aimed to validate the ADAPT scores for predicting ischemic and bleeding events in patients ...
Go YH +10 more
europepmc +3 more sources
Dual Antiplatelet Therapy in Patients With Minor Stroke Receiving Intravenous Thrombolysis
Frontiers in Neurology, 2022 IntroductionConcern over the potential severe bleeding risk of dual antiplatelet therapy for patients with minor stroke after intravenous thrombolysis (IVT) leads to different antiplatelet strategies in the secondary prevention of stroke.
Zhaohan Xu +7 more
doaj +1 more source